142 related articles for article (PubMed ID: 22410411)
1. Sensitivity of Medicare claims data for measuring use of standard multiagent chemotherapy regimens.
Lamont EB; Lan L
Med Care; 2014 Mar; 52(3):e15-20. PubMed ID: 22410411
[TBL] [Abstract][Full Text] [Related]
2. Criterion validity of Medicare chemotherapy claims in Cancer and Leukemia Group B breast and lung cancer trial participants.
Lamont EB; Herndon JE; Weeks JC; Henderson IC; Lilenbaum R; Schilsky RL; Christakis NA
J Natl Cancer Inst; 2005 Jul; 97(14):1080-3. PubMed ID: 16030306
[TBL] [Abstract][Full Text] [Related]
3. Measuring clinically significant chemotherapy-related toxicities using Medicare claims from Cancer and Leukemia Group B (CALGB) trial participants.
Lamont EB; Herndon JE; Weeks JC; Henderson IC; Lilenbaum R; Schilsky RL; Christakis NA;
Med Care; 2008 Mar; 46(3):303-8. PubMed ID: 18388845
[TBL] [Abstract][Full Text] [Related]
4. Hospital-based health care use correlates with incidence of adverse events among elderly Medicare patients treated in adjuvant chemotherapy trials (Alliance 70802).
Lamont EB; Yu M; He Y; Saltz L; Muss H; Zaslavsky AM;
J Geriatr Oncol; 2014 Jul; 5(3):230-7. PubMed ID: 24594119
[TBL] [Abstract][Full Text] [Related]
5. Importance of multiagent chemotherapy regimens in ovarian carcinoma: dose intensity analysis.
Levin L; Simon R; Hryniuk W
J Natl Cancer Inst; 1993 Nov; 85(21):1732-42. PubMed ID: 8411257
[TBL] [Abstract][Full Text] [Related]
6. Construct validity of medicare chemotherapy claims: the case of 5FU.
Lamont EB; Lauderdale DS; Schilsky RL; Christakis NA
Med Care; 2002 Mar; 40(3):201-11. PubMed ID: 11880793
[TBL] [Abstract][Full Text] [Related]
7. Measuring disease-free survival and cancer relapse using Medicare claims from CALGB breast cancer trial participants (companion to 9344).
Lamont EB; Herndon JE; Weeks JC; Henderson IC; Earle CC; Schilsky RL; Christakis NA;
J Natl Cancer Inst; 2006 Sep; 98(18):1335-8. PubMed ID: 16985253
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of irinotecan-based chemotherapy regimens in elderly Medicare patients with metastatic colorectal cancer.
Obeidat NA; Pradel FG; Zuckerman IH; DeLisle S; Mullins CD
Am J Geriatr Pharmacother; 2009 Dec; 7(6):343-54. PubMed ID: 20129255
[TBL] [Abstract][Full Text] [Related]
9. Costs associated with intravenous chemotherapy administration in patients with small cell lung cancer: a retrospective claims database analysis.
Duh MS; Reynolds Weiner J; Lefebvre P; Neary M; Skarin AT
Curr Med Res Opin; 2008 Apr; 24(4):967-74. PubMed ID: 18282373
[TBL] [Abstract][Full Text] [Related]
10. Identifying specific chemotherapeutic agents in Medicare data: a validation study.
Lund JL; Stürmer T; Harlan LC; Sanoff HK; Sandler RS; Brookhart MA; Warren JL
Med Care; 2013 May; 51(5):e27-34. PubMed ID: 22080337
[TBL] [Abstract][Full Text] [Related]
11. Generalizability of trial results to elderly Medicare patients with advanced solid tumors (Alliance 70802).
Lamont EB; Schilsky RL; He Y; Muss H; Cohen HJ; Hurria A; Meilleur A; Kindler HL; Venook A; Lilenbaum R; Niell H; Goldberg RM; Joffe S;
J Natl Cancer Inst; 2015 Jan; 107(1):336. PubMed ID: 25432408
[TBL] [Abstract][Full Text] [Related]
12. Validity of claims-based stroke algorithms in contemporary Medicare data: reasons for geographic and racial differences in stroke (REGARDS) study linked with medicare claims.
Kumamaru H; Judd SE; Curtis JR; Ramachandran R; Hardy NC; Rhodes JD; Safford MM; Kissela BM; Howard G; Jalbert JJ; Brott TG; Setoguchi S
Circ Cardiovasc Qual Outcomes; 2014 Jul; 7(4):611-9. PubMed ID: 24963021
[TBL] [Abstract][Full Text] [Related]
13. Limited validity of diagnosis codes in Medicare claims for identifying cancer metastases and inferring stage.
Chawla N; Yabroff KR; Mariotto A; McNeel TS; Schrag D; Warren JL
Ann Epidemiol; 2014 Sep; 24(9):666-72, 672.e1-2. PubMed ID: 25066409
[TBL] [Abstract][Full Text] [Related]
14. Comparative and cost-effectiveness of oxaliplatin-based or irinotecan-based regimens compared with 5-fluorouracil/leucovorin alone among US elderly stage IV colon cancer patients.
Mullins CD; Hsiao FY; Onukwugha E; Pandya NB; Hanna N
Cancer; 2012 Jun; 118(12):3173-81. PubMed ID: 22020739
[TBL] [Abstract][Full Text] [Related]
15. Use of Bevacizumab for Elderly Patients With Stage IV Colon Cancer: Analysis of SEER-Medicare Data.
Raab GT; Lin A; Hillyer GC; Keller D; O'Neil DS; Accordino MK; Buono DL; Hur C; Kiran RP; Wright JD; Hershman DL; Neugut AI
Clin Colorectal Cancer; 2019 Sep; 18(3):e294-e299. PubMed ID: 31266707
[TBL] [Abstract][Full Text] [Related]
16. Modified XELIRI (capecitabine plus irinotecan) versus FOLFIRI (leucovorin, fluorouracil, and irinotecan), both either with or without bevacizumab, as second-line therapy for metastatic colorectal cancer (AXEPT): a multicentre, open-label, randomised, non-inferiority, phase 3 trial.
Xu RH; Muro K; Morita S; Iwasa S; Han SW; Wang W; Kotaka M; Nakamura M; Ahn JB; Deng YH; Kato T; Cho SH; Ba Y; Matsuoka H; Lee KW; Zhang T; Yamada Y; Sakamoto J; Park YS; Kim TW
Lancet Oncol; 2018 May; 19(5):660-671. PubMed ID: 29555258
[TBL] [Abstract][Full Text] [Related]
17. Agreement of Medicare claims and tumor registry data for assessment of cancer-related treatment.
Cooper GS; Yuan Z; Stange KC; Dennis LK; Amini SB; Rimm AA
Med Care; 2000 Apr; 38(4):411-21. PubMed ID: 10752973
[TBL] [Abstract][Full Text] [Related]
18. Patterns of use of chemotherapy for breast cancer in older women: findings from Medicare claims data.
Du X; Goodwin JS
J Clin Oncol; 2001 Mar; 19(5):1455-61. PubMed ID: 11230491
[TBL] [Abstract][Full Text] [Related]
19. Ability of Medicare claims data to identify nursing home patients: a validation study.
Koroukian SM; Xu F; Murray P
Med Care; 2008 Nov; 46(11):1184-7. PubMed ID: 18953230
[TBL] [Abstract][Full Text] [Related]
20. FOLFOX and FOLFIRI Use in Stage IV Colon Cancer: Analysis of SEER-Medicare Data.
Neugut AI; Lin A; Raab GT; Hillyer GC; Keller D; O'Neil DS; Accordino MK; Kiran RP; Wright J; Hershman DL
Clin Colorectal Cancer; 2019 Jun; 18(2):133-140. PubMed ID: 30878317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
